Product image of Glucosum (Glucose) supplied by GNH India

Glucosum

Active Ingredient:
Glucose
Origin:
EU

Glucosum (Glucose)

Glucosum is a pharmaceutical product containing glucose as its sole active ingredient. It is supplied in an unspecified strength and dosage form, and is marketed in the European Union. Glucose functions as an energy source and osmotic agent, and Glucosum may be administered via intra‑articular, intravenous, or peri‑articular routes under appropriate clinical supervision. The product is classified as an excipient and is listed under ATC code A12AA01.

Manufacturer / TM Owner

Teva Pharmaceuticals Polska Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosum provides glucose for clinical situations where an immediate source of carbohydrate or osmotic balance is required.

  • Intravenous administration to supply energy during surgery or critical care.
  • Intra‑articular injection as an osmotic agent to aid joint lavage.
  • Peri‑articular use to support tissue healing after orthopedic procedures.
  • Diluent or carrier in parenteral nutrition formulations.
  • Adjunct in diagnostic imaging procedures that require a glucose load.

Side Effects

Glucose administered as Glucosum is generally well tolerated, but adverse reactions can occur.

Common

  • Transient hyperglycemia.
  • Local irritation at the injection site.
  • Mild nausea or vomiting.
  • Headache or dizziness.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reaction such as urticaria or anaphylaxis.
  • Electrolyte imbalance, particularly hyponatremia.
  • Volume overload in patients with cardiac failure.

Precautions & Warnings

When using Glucosum, clinicians should evaluate patient-specific factors and monitor for potential complications.

  • Assess blood glucose levels before and after administration.
  • Use caution in patients with diabetes mellitus or impaired glucose tolerance.
  • Avoid rapid infusion in individuals at risk for fluid overload.
  • Consider renal or hepatic impairment that may affect glucose metabolism.
  • Monitor for signs of electrolyte disturbances during prolonged therapy.
  • Evaluate for hypersensitivity history prior to intra‑articular use.

Avoid Interactions

Glucosum may interact with other agents that influence glucose homeostasis or fluid balance.

Avoid

  • Concomitant use of high‑dose insulin or other hypoglycemic agents without dose adjustment.
  • Co‑administration with large volumes of dextrose‑containing solutions that could cause severe hyperglycemia.
  • Simultaneous infusion of potassium‑rich solutions in patients prone to hyperkalemia.

Use with caution

  • Medications that affect renal function such as NSAIDs or ACE inhibitors.
  • Drugs that alter electrolyte status, for example loop diuretics.
  • Anesthetic agents that may mask signs of glucose imbalance.

Frequently Asked Questions

The active ingredient in Glucosum is glucose.

Glucosum can be administered intra‑articularly, intravenously, or peri‑articularly.

Glucose creates an osmotic gradient that helps draw fluid into a compartment, which is useful in joint lavage and tissue hydration.

Glucosum is classified as an excipient, listed under the drug class "Excipient".

Common side effects include transient hyperglycemia, local irritation at the injection site, mild nausea or vomiting, and headache or dizziness.

Serious reactions may include severe hyperglycemia, allergic reactions such as urticaria or anaphylaxis, electrolyte imbalance, and volume overload in patients with cardiac failure.

Patients with diabetes, impaired glucose tolerance, renal or hepatic impairment, cardiac failure, or electrolyte disorders should be monitored closely.

Glucosum can be used with insulin, but dose adjustments and close glucose monitoring are recommended to avoid hypoglycemia.

Yes, concurrent administration of high‑dose dextrose solutions or potassium‑rich fluids may increase the risk of severe hyperglycemia or electrolyte disturbances.

The regulatory status of Glucosum (prescription vs. OTC) is not specified; it should be used under medical supervision.

In orthopedic procedures, Glucosum may be injected intra‑articularly or peri‑articularly as an osmotic agent to aid joint lavage and support tissue healing.

Monitoring should include blood glucose levels, electrolytes, fluid balance, and observation for any signs of hypersensitivity or adverse reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.